logo

For the Inventor, By the Inventor

Stonington, CT, United States of America

Gary R Schulte

USPTO Granted Patents = 14


Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 259(Granted Patents)


Location History:

  • Stonington, CT (US) (1991 - 1997)
  • Groton, CT (US) (1997 - 2001)

Company Filing History:

goldMedal14 out of 4,459 
 
Pfizer Corporation
 patents

Years Active: 1991-2001

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 6174883 - 3-substituted-2-oxindoles derivatives (2001-01-16),
2. 5919809 - 3-substituted-2-oxindole derivatives (1999-07-06),
3. 5648502 - Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid (1997-07-15),
4. 5631235 - 2-Aminosugar derivatives of macrolides (1997-05-20),
5. 5593997 - 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine (1997-01-14),
6. 5563135 - Desosamino derivatives of macrolides (1996-10-08),
7. 5506233 - Desosamino derivatives of macrolides as immunosuppressants and (1996-04-09),
8. 5432183 - Use of rapamycin prodrugs as immunosuppressant agents (1995-07-11),
9. 5300655 - 2-carboxy-thiophene derivatives (1994-04-05),
10. 5290802 - 3-substituted-2-oxindole derivatives (1994-03-01),
11. 5192790 - 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 (1993-03-09),
12. 5064851 - 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use (1991-11-12),
13. 5059693 - Process for making 3-aroyl-2-oxindole-1-carboxamides (1991-10-22),
14. 5047554 - 3-substituted-2-oxindole derivatives (1991-09-10),

Title: Gary R Schulte: A Pioneer in Pharmaceutical Innovations

Introduction

Gary R Schulte, an accomplished inventor based in Stonington, Connecticut, has made significant contributions in the pharmaceutical field. With a remarkable portfolio of 14 patents, Schulte is known for his innovative approach to drug development and his role in addressing chronic inflammatory diseases.

Latest Patents

Among his latest inventions is a series of novel 3-substituted-2-oxindole derivatives. These innovative compounds are designed to inhibit prostaglandin H₂ synthase, 5-lipoxygenase, and interleukin-1 biosynthesis. The patented compounds not only serve as effective inhibitors but also have applications as analgesic, anti-inflammatory, and anti-arthritic agents. Such capabilities make them valuable in treating chronic inflammatory conditions. Additionally, Schulte's invention encompasses pharmaceutical compositions that include these 3-substituted-2-oxindole derivatives, outlining methods for their synthesis and use in medical treatments.

Career Highlights

Gary R Schulte has been affiliated with Pfizer Corporation, a leading global pharmaceutical company. His expertise has greatly contributed to the advancement of therapeutic interventions, showcasing his commitment to improving health outcomes through scientific invention.

Collaborations

Throughout his career, Schulte has collaborated with notable colleagues such as Carl J Goddard and Frederick J Ehrgott. These partnerships have fostered an environment of innovative thinking and teamwork, further enhancing the development of groundbreaking pharmaceutical solutions.

Conclusion

In summary, Gary R Schulte continues to pave the way for advancements in drug development with his inventive spirit and dedication to improving health. His work exemplifies the significant impact inventors have in transforming scientific ideas into life-changing medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…